Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 5/2019

01-10-2019 | Commentary

Overuse of intravenous infusions in China: focusing on management platform and cultural problems

Authors: Shuangshuang Zeng, Dong Wang, Wanli Liu, Yuanliang Yan, Minwen Zhu, Zhicheng Gong, Shusen Sun

Published in: International Journal of Clinical Pharmacy | Issue 5/2019

Login to get access

Abstract

This article reviews the current status of the overuse of intravenous (IV) infusions in China and implications to patient safety, and analyzes factors associated with the overuse. Although many factors contribute to the overuse of IV infusions in China, we focus on the construction of an IV infusion management system and tackling cultural problems as the first step to address issues of IV therapy in this commentary.
Literature
1.
2.
Wang H, Xie X, Liu Z, Yang Z. Evaluation of the inpatient usage of intravenous infusion in 156 hospitals. J Pharm Pract. 2017;35(6):573–6.
3.
Gao X, Chen L, Deng R, Xia Y, Chen J, Chen X. Current situation, hazards and countermeasures against the overuse of intravenous infusion. Progr Pharm Sci. 2016;40(2):141–4.
4.
Zhang Z, Hu Y, Zou G, Lin M, Zeng J, Deng S, et al. Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions. Glob Health Action. 2017;10(1):1287334.CrossRefPubMedPubMedCentral
5.
6.
7.
Zhao Y, Wang T, Li G, Sun S. Pharmacovigilance in China: development and challenges. Int J Clin Pharm. 2018;40(4):823–31.CrossRefPubMed
8.
Li X, Thai S, Lu W, Sun S, Tang H, Zhai S, et al. Traditional Chinese medicine and drug-induced anaphylaxis: data from the Beijing pharmacovigilance database. Int J Clin Pharm. 2018;40(4):921–7.CrossRefPubMed
9.
Lobo DN, Dube MG, Neal KR, Simpson J, Rowland BJ, Allison SP. Problems with solutions: drowning in the brine of inadequate knowledge base. Clin Nutr. 2001;20:125–30.CrossRefPubMed
10.
Reynolds L, McKee M. Serve the people or close the sale? Profit-driven overuse of injections and infusions in China’s market-based healthcare system. Int J Health Plan Manag. 2011;26(4):449–70.CrossRef
11.
Kan J, Zhu X, Wang T, Lu R, Spencer PS. Chinese patient demand for intravenous therapy: a preliminary survey. The Lancet. 2015;386:S61.CrossRef
12.
13.
Wang D, Gong Z, Lei G. Design and practice of rational and safe intravenous infusion integration management. Chin Hosp. 2018;22(8):57–8.
14.
15.
Zeng S, Chen X, Liu W, Yin T, Gong Z. Medication analysis of intravenous infusion in critically ill patients in a hospital. Chin Hosp Pharm J. 2018;38(16):1750–4.
16.
Zeng S, Wang D, Liu W, Gong Z. Integration management practice of rational and safe infusion based on the “medicine–pharmacy–nursing” monitor-control and early warning system. Chin Hosp Pharm J. 2019;39(7):98–103.
17.
Li H, Wang S, Yue Z, Ren X, Xia J. Traditional Chinese herbal injection: current status and future perspectives. Fitoterapia. 2018;129:249–56.CrossRefPubMed
18.
19.
Pérez Fidalgo JA, Garcia Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F, et al. Management of chemotherapy extravasation: ESMO–EONS clinical practice guidelines. Eur J Oncol Nurs. 2012;16(5):528–34.CrossRefPubMed
Metadata
Title
Overuse of intravenous infusions in China: focusing on management platform and cultural problems
Authors
Shuangshuang Zeng
Dong Wang
Wanli Liu
Yuanliang Yan
Minwen Zhu
Zhicheng Gong
Shusen Sun
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00898-0

Other articles of this Issue 5/2019

International Journal of Clinical Pharmacy 5/2019 Go to the issue

Short Research Report

An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland

Research Article

Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study

Research Article

Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016

Research Article

Healthcare personnel’s experience of reporting adverse drug reactions in Baghdad city: cross-sectional study

Research Article

Evaluating the Connect with Pharmacy web-based intervention to reduce hospital readmission for older people

Research Article

Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits